Scroll Top
Perspectives
Gain Therapeutics Inc.
Clear Filters
Michael J. Fox Foundation poster
Parkinson’s Disease Therapeutics by Michael J. Fox Foundation 2024
October 21, 2024
Parkinson’s Disease Therapeutics by Michael J. Fox Foundation 2024
Read More
a scientist testing samples
Human Clinical Trials: Single & Multiple Ascending Dose (SAD & MAD) Studies
October 2, 2024
Human Clinical Trials: Single & Multiple Ascending Dose (SAD & MAD) Studies
Read More
a conference meet in a vast hall
H.C. Wainwright Global Investment Conference & International Congress of Parkinson’s Disease and Movement Disorders
September 24, 2024
H.C. Wainwright Global Investment Conference & International Congress of Parkinson’s Disease and Movement Disorders
Read More
Rayn Reynolds and his father
Ryan Reynolds Shares His Father’s Early Parkinson’s Symptoms: Subtle Signs His Family Missed
September 24, 2024
Ryan Reynolds Shares His Father’s Early Parkinson’s Symptoms: Subtle Signs His Family Missed
Read More
molecule structure
Biomarkers and Their Role in Neurodegenerative Diseases
September 24, 2024
Biomarkers and Their Role in Neurodegenerative Diseases
Read More
Gain-160824-2
Gain Therapeutics Discusses with Ram Selvaraju at H.C. Wainwright’s Annual Neuro Perspectives Virtual Conference
September 24, 2024
Gain Therapeutics Discusses with Ram Selvaraju at H.C. Wainwright’s Annual Neuro Perspectives Virtual Conference
Read More
perspective-thumbnail_20240809
GT-02287: A Promising GCase Enhancer in the Fight Against GBA1-Parkinson’s Disease
September 24, 2024
GT-02287: A Promising GCase Enhancer in the Fight Against GBA1-Parkinson’s Disease
Read More
blog-perspective-1
The role of the immune system in neurodegenerative diseases
September 24, 2024
The role of the immune system in neurodegenerative diseases
Read More
blog-perspective-20240627_close-up-hands-with-golden-ring
Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I
September 24, 2024
Discovery of allosteric regulators with clinical potential to stabilize alpha-L-iduronidase in mucopolysaccharidosis type I
Read More
Corporate Presentation
August 2024
Corporate Presentation
Download